InvestorsObserver
×
News Home

Will Lexaria Bioscience Corp (LEXX) Beat the Rest of the Stocks in the Healthcare Sector?

Thursday, November 09, 2023 10:45 AM | InvestorsObserver Analysts

Mentioned in this article

Will Lexaria Bioscience Corp (LEXX) Beat the Rest of the Stocks in the Healthcare Sector?

The 59 rating InvestorsObserver gives to Lexaria Bioscience Corp (LEXX) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 94 percent of stocks in the Healthcare sector, LEXX’s 59 overall rating means the stock scores better than 59 of all stocks.

Overall Score - 59
LEXX has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on LEXX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Lexaria Bioscience Corp Stock Today?

Lexaria Bioscience Corp (LEXX) stock has risen 0.96% while the S&P 500 has fallen -0.21% as of 10:41 AM on Thursday, Nov 9. LEXX is higher by $0.01 from the previous closing price of $1.57 on volume of 8,906 shares. Over the past year the S&P 500 is higher by 16.67% while LEXX has fallen -29.78%. LEXX lost -$1.13 per share the over the last 12 months. Click Here to get the full Stock Report for Lexaria Bioscience Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App